TERRA-CORTRIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Terra-cortril, and when can generic versions of Terra-cortril launch?
Terra-cortril is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in TERRA-CORTRIL is hydrocortisone acetate; oxytetracycline hydrochloride. There are sixty-seven drug master file entries for this compound. Additional details are available on the hydrocortisone acetate; oxytetracycline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TERRA-CORTRIL?
- What are the global sales for TERRA-CORTRIL?
- What is Average Wholesale Price for TERRA-CORTRIL?
Summary for TERRA-CORTRIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 109 |
| Clinical Trials: | 8 |
| Patent Applications: | 4,356 |
| DailyMed Link: | TERRA-CORTRIL at DailyMed |
Recent Clinical Trials for TERRA-CORTRIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 1 |
| Children's Oncology Group | Phase 1 |
| EsPhALL network I-BFM Study Group | Phase 3 |
US Patents and Regulatory Information for TERRA-CORTRIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | TERRA-CORTRIL | hydrocortisone acetate; oxytetracycline hydrochloride | SUSPENSION;OPHTHALMIC | 061016-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
